A Molecular Prognostic Model Predicts Esophageal Squamous Cell Carcinoma Prognosis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Molecular Prognostic Model Predicts Esophageal Squamous Cell Carcinoma Prognosis
Authors
Keywords
Biomarkers, Cell staining, Squamous cell carcinomas, Cytoplasmic staining, Surgical and invasive medical procedures, Membrane staining, Cancer treatment, Cancer chemotherapy
Journal
PLoS One
Volume 9, Issue 8, Pages e106007
Publisher
Public Library of Science (PLoS)
Online
2014-08-26
DOI
10.1371/journal.pone.0106007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis
- (2013) Vanessa Y Tan et al. BMC Medicine
- Epidermal Growth Factor Receptor (EGFR)-RAS Signaling Pathway in Penile Squamous Cell Carcinoma
- (2013) Hong-Feng Gou et al. PLoS One
- Overexpression of Jumonji AT-rich interactive domain 1B and PHD finger protein 2 is involved in the progression of esophageal squamous cell carcinoma
- (2012) Ling-Ling Sun et al. ACTA HISTOCHEMICA
- Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas
- (2012) Isabela Martins Gonzaga et al. BMC CANCER
- Promising outcomes of definitive chemoradiation and cetuximab for patients with esophageal squamous cell carcinoma
- (2012) Yongshun Chen et al. CANCER SCIENCE
- A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma
- (2012) I. Garcia et al. CLINICAL CANCER RESEARCH
- ColoGuidePro: A Prognostic 7-Gene Expression Signature for Stage III Colorectal Cancer Patients
- (2012) A. Sveen et al. CLINICAL CANCER RESEARCH
- Targeting the EGFR signaling pathway in cancer therapy
- (2012) Parthasarathy Seshacharyulu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer
- (2012) Lisa A. Carey et al. JOURNAL OF CLINICAL ONCOLOGY
- Overexpression of Sigma1 Receptor and Its Positive Associations With Pathologic TNM Classification in Esophageal Squamous Cell Carcinoma
- (2012) Qing-Xia Xu et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma
- (2011) Lin-wei Li et al. BMC CANCER
- Specificity protein 1 regulates fascin expression in esophageal squamous cell carcinoma as the result of the epidermal growth factor/extracellular signal-regulated kinase signaling pathway activation
- (2010) Xiao-Feng Lu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma Prognosis
- (2010) Humam Kadara et al. CLINICAL CANCER RESEARCH
- A 4-Gene Signature Predicts Survival of Patients With Resected Adenocarcinoma of the Esophagus, Junction, and Gastric Cardia
- (2010) Christopher J. Peters et al. GASTROENTEROLOGY
- High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma
- (2010) X.-R. Yang et al. GUT
- Phosphorylation of Fascin Decreases the Risk of Poor Survival in Patients With Esophageal Squamous Cell Carcinoma
- (2010) Qing Zhao et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Migrastatin analogues target fascin to block tumour metastasis
- (2010) Lin Chen et al. NATURE
- A Three-Gene Signature for Outcome in Soft Tissue Sarcoma
- (2009) A.-C. Hoffmann et al. CLINICAL CANCER RESEARCH
- Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR
- (2008) Volker Heinemann et al. CANCER TREATMENT REVIEWS
- Revised Guidelines Signal That Gene Expression Profiles Are Coming of Age
- (2008) Steve Benowitz JNCI-Journal of the National Cancer Institute
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now